AWP Drumbeat Continues With McKesson’s $151 Mil. Medicaid Fraud Settlement With States
This article was originally published in The Pink Sheet Daily
The settlement resolves claims McKesson inflated the average wholesale price of more than 1,400 brand drugs.
You may also be interested in...
Wholesale drug distributor McKesson settles charges that it reported inflated average wholesale prices (AWPs) for a large number of branded prescription pharmaceuticals, leading to extensive overpayments by the Medicaid program.
The heavy docket of average wholesale price cases got a bit lighter as three pharma companies agreed to pay $421 million to settle claims they inflated the AWP of numerous drugs, thus increasing reimbursement levels.
Complaint lists host of problems with implementation of the rule that allows states to sponsor programs to import certain prescription drugs from Canada; at least six states have enacted legislation to sponsor these programs.